Art. 8b NarcA from 2023
Art. 8b (1) Collecting data on medical treatment using narcotics containing an effective concentration of Cannabis
1 The FOPH shall collect data on medical treatments using narcotics containing an effective concentration of cannabis (medicinal cannabis products) that:a. are not authorised;b. are authorised but are prescribed for an indication other than the authorised indication and used in a form other than the authorised pharmaceutical form.
2 The data is collected for:a. the scientific evaluation under Article 29a; andb. statistical analysis.
3 The FOPH shall make the results of the statistical analysis available to:a. the cantonal executive authorities;b. the doctors involved in the treatment;c. research institutions that are interested.
(1) Inserted by No I of the FA of 19 March 2021, in force from 1. Aug. 2022 until 31 July 2029 ([AS 2022 385]; [BBl 2020 6069]).
Es besteht kein Anspruch auf Aktualität und Vollständigkeit/Richtigkeit.